Accessibility settings

This paper is in the following e-collection/theme issue:

Infodemiology and Infoveillance (2024) Peer-to-Peer Support and Online Communities (1008) Eating Disorders (137) Obesity and Nutrition as Public Health Problem (597)

Published on in Vol 28 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/78391, first published .
Person preparing to use a blood glucose monitoring device

Patient Perceptions of Ozempic (Semaglutide) for Weight Loss: Mixed Methods Analysis of Online Medication Reviews

Patient Perceptions of Ozempic (Semaglutide) for Weight Loss: Mixed Methods Analysis of Online Medication Reviews

Authors of this article:

Abanoub J Armanious1, 2 Author Orcid Image ;   Rachel-Mae Hunter1, 2 Author Orcid Image ;   Kristi R Griffiths3 Author Orcid Image ;   Hannah E Bowrey4, 5 Author Orcid Image ;   Robyn M Brown6 Author Orcid Image ;   Morgan H James1, 2, 4, 5 Author Orcid Image
Article Authors Cited by (2) Tweetations (3) Metrics

Journals

  1. Shah E, AlShiab R, Abdo A, Ozbek L, Covic A, Kanbay M. Clinical Management of Weight Regain and Cardiometabolic Consequences After Discontinuation of GLP‐1 Receptor Agonists. Diabetes, Obesity and Metabolism 2026;28(6):4546 View
  2. Armanious A, Dunn A, Martin C, James M. Perceived Effectiveness, Tolerability, and Discontinuation of Lemborexant in Real-World Use: Evidence from Online Patient Reports. Sleep Medicine 2026:109264 View